Xiaoming Xin

Dr. Xiaoming Xin

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
XXXiaoming Xin
Xiaoming Xin
YNYaohua Ni
Yaohua Ni
JWJing Wang
Jing Wang
FWFenglin Wu
Fenglin Wu
MLMeichen Liu
Meichen Liu
XZXianmin Zhu
Xianmin Zhu
Macrophages play important roles in metabolic dysfunction-associated steatohepatitis (MASH), an advanced and inflammatory stage of metabolic dysfunction-associated steatotic liver disease (MASLD). In humans and mice, the cellular heterogeneity and diverse function of hepatic macrophages in MASH have been investigated by single cell RNA sequencing (scRNA-seq). However, little is known about their roles in rats. Here, we collected liver tissues at the postnatal week 16, when our previously characterized Lep∆I14/∆I14 rats developed MASH phenotypes. By scRNA-seq, we found an increase in the number of macrophages and endothelial cells and a decrease in that of NK and B cells. Hepatic macrophages in rats underwent a unique M1 to M2 transition without expression of the classical markers such as Arg1 and Nos2, except for Cd163. Lipid-associated macrophages (LAMs) were increased, which could be detected by the antibody against Cd63. In the microenvironment, macrophages had an increased number of interactions with hepatocytes, myofibroblasts, T cells, neutrophils, and dendritic cells, while their interaction strengths remained unchanged. Finally, the macrophage migration inhibitory factor (MIF) pathway was identified as the top upregulated cell-communication pathway in MASH. In conclusion, we dissected hepatic macrophage dynamics during MASH at single cell resolution and provided fundamental tools for the investigation of MASH in rat models.

24 July 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
XXXiaoming Xin
Xiaoming Xin
LMLei Miao
Lei Miao
LCLei Ci
Lei Ci
YWYun Wang
Yun Wang
ZZZhiguo Zhang
Zhiguo Zhang
Yi Zhun ZhuYi Zhun Zhu
Yi Zhun Zhu
Introduction: Stroke, predominantly ischemic, is a leading cause of mortality and disability worldwide. Despite advances in intervention strategies, effective treatments to mitigate neurological injury post‐ischemic stroke remain limited. Hydrogen sulfide (H2S), a gas signaling molecule, has been implicated in neuroprotection, but its role in stroke is controversial. S‐propargyl‐cysteine (SPRC), an H2S donor, has shown great potential in protecting against neurological injuries, but its mechanisms in ischemic stroke are not fully understood. This study investigates the neuroprotective potential of SPRC and its mechanisms, focusing on the interplay between H2S and autophagy in modulating the cerebral microenvironment post‐stroke.Methods: We conducted a comprehensive single‐cell RNA sequencing analysis on ischemic brain tissue to elucidate the cellular heterogeneity and specific responses related to H2S synthesis and autophagy. We utilized the GEO repository dataset GSE174574, applying stringent filtering and batch effect correction using the Harmony R package. Cellular subpopulations were identified using established markers, and H2S and autophagy scores were calculated using the JASMINE package. We also measured serum H2S levels, evaluated the pharmacodynamics of SPRC in rats, and constructed a cerebral ischemia–reperfusion (I/R) injury model to assess the neuroprotective effects of SPRC. Additionally, we examined the role of SPRC in CBS and 3‐MST knockout mice to determine the dependency on these H2S synthetases.Results: Our findings revealed a dysregulation in the expression of H2S and autophagy‐related genes in central nervous system cells, particularly in neurons, following stroke. SPRC administration significantly improved neurological behavior, metabolic activity, reduced brain infarction size, and ameliorated ultrastructure changes in stroke‐affected rats. Interestingly, SPRC continued to provide neuroprotection even after the knockdown of CBS and 3‐MST, indicating a CBS/3‐MST‐independent mechanism. Furthermore, SPRC preserved the endogenous H2S level and strongly upregulated protective autophagy.Conclusion: This study is the first to reveal the neuroprotection of SPRC in cerebral I/R injury in a classical enzymatic CBS/3‐MST independent manner. The potential cellular and molecular mechanisms may rely on the promotion of SPRC to activated protective autophagy. Our results suggest that SPRC could be a promising therapeutic candidate for enhancing neuroprotection and modulating autophagy in ischemic stroke.